Changing paradigms in the management of differentiated thyroid cancer
Please note that for mobiles we stream the presentation slides and audio of the speaker.
You must login to watch this lecture.
This video has been archived as it is more than 2 years old. CPD is no longer available.
Professor Mehanna speaks about the evolving guidelines and practices for the management of differentiated thyroid cancer. In particular Hisham looks at the changing paradigms surrounding incidence rate, personalisation of therapy, risk stratification and follow-up, and mortality. Hisham uses data from various clinical trials and publications to support his discussion.
This lecture was part of the 'thyroid (malignant)' event. It was held at The Royal Society of Medicine in London.
Date of lecture: 1st May 2015
This video is available for iPad via Safari
Tips about RSM Videos
- This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
- The CPD process for this video has now expired. Previously booked CPD credits can still be accessed after login.
- Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
- Click on the Chapters tab to view different parts of the video.